poisar

Stocks · News reference

European Commission Approves Ionis' TRYNGOLZA™ for Severe Hypertriglyceridemia

Fiscal.ai

The European Commission has authorized TRYNGOLZA™ (olezarsen) as an adjunct to diet and lipid-lowering therapies for adult patients with severe hypertriglyceridemia.

Reference Details

Connected Markets

Poisar stores the source's headline, summary and market tags for reference. Reporting and full article text remain with the original publisher.

Source
fiscal.ai
Observed
Checked
Cadence
Captured once, then retained as an archive reference
Status
fresh

Keep reading